MHLW and PMDA to join Project Orbis for oncology drug lag/loss (announcement)
厚生労働省及びPMDAはProject Orbisに参加します ～抗がん剤領域におけるドラッグラグ・ロスの解消を目指します～
Published: 2026-09-11 · Source: Ministry of Health, Labour and Welfare (MHLW) · Stage: Government Announcement · Area: Labor / Employment · Impact (preliminary): Medium · First detected by this dashboard: 2026-09-12
View the original Japanese source More Labor / Employment updates Search all updates in the dashboard
AI summary
Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.
Summary
This is a government announcement on the MHLW website stating that the Ministry of Health, Labour and Welfare and the PMDA will participate in Project Orbis. The title says the aim is to address drug lag and drug loss in the field of anticancer drugs. No further details, such as participation terms or timing, were provided in the metadata.
Business Impact
This could be relevant to pharmaceutical and biotech companies developing oncology products and considering regulatory submissions in Japan. The practical effect on review timelines or procedures is not stated in the available information.
Recommended Action
Review the official MHLW announcement to confirm the scope of participation and any implications for oncology drug applications.